Peculiarities of surgical treatment of patients with gastroesophageal reflux disease
Objective. To analyze the effectiveness of various methods of laparoscopic antireflux operations in patients with gastroesophageal reflux disease.
Materials and methods. The results of treatment of 177 patients with gastroesophageal reflux disease from 2015 to 2021 were analyzed. Patients were divided into three groups: 1st - 62 patients who underwent laparoscopic antireflux surgery of our own modification (Patent of Ukraine No 59772); 2nd - 91 patients who underwent laparoscopic Nissen fundoplication; 3rd - 24 patients who underwent laparoscopic Toupet fundoplication.
Results. 36 months after surgery in the 1st group the recurrence rate of gastroesophageal disease was 1.6%, recurrence of hernia of the esophageal orifice - 1.6%, in the 2nd group - 7.7 and 3.3%, respectively; in the 3rd group - 12.5 and 8.3%, respectively.
Conclusions. The application of a new integrated approach to the surgical treatment of gastroesophageal reflux disease reduces the number of postoperative complications (gas -bloat syndrome - 3 times, dysphagia - 5 times), the recurrence rate of gastroesophageal reflux disease - 5 times and recurrence of esophageal hernia - 2 times, improves the quality of life of patients 36 months after surgery in 2.6 times and increases the timeliness of diagnosis and facilitates the choice of differentiated treatment tactics.
Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, et al. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014 Jun;28(6):1753-73. doi: 10.1007/s00464-014-3431-z. Epub 2014 May 2. PMID: 24789125.
El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871-80. doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13. PMID: 23853213; PMCID: PMC4046948.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444. Epub 2013 Feb 19. Erratum in: Am J Gastroenterol. 2013 Oct;108(10):1672. PMID: 23419381.
McKinley SK, Dirks RC, Walsh D, Hollands C, Arthur LE, Rodriguez N, et al. Surgical treatment of GERD: systematic review and meta-analysis. Surg Endosc. 2021 Mar 2. doi: 10.1007/s00464-021-08358-5. Epub ahead of print. PMID: 33651167.
Scarpellini E, Ang D, Pauwels A, De Santis A, Vanuytsel T, Tack J. Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol. 2016 May;13(5):281-94. doi: 10.1038/nrgastro.2016.50. Epub 2016 Apr 14. PMID: 27075264.
Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, et al. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med. 2006 Jul;209(3):181-9. doi: 10.1620/tjem.209.181. PMID: 16778364.
Andreou A, Watson DI, Mavridis D, Francis NK, Antoniou SA. Assessing the efficacy and safety of laparoscopic antireflux procedures for the management of gastroesophageal reflux disease: a systematic review with network meta-analysis. Surg Endosc. 2020 Feb;34(2):510-520. doi: 10.1007/s00464-019-07208-9. Epub 2019 Oct 18. PMID: 31628621.
Memon MA, editor. Hiatal hernia surgery: An evidence based approach. Cham, Germany: Springer International Publishing; 2018. 309 p. ISBN 978-3-319-64003-7 doi: 10.1007/978-3-319-64003-7.
Fomin PD, Grubnik VV, Nikishaev VI, Malinovsky AV. Non-neoplastic diseases of the esophagus. Kiev: Business Intellect; 2008.304 p. Russian. ISBN 978-966-1653-00-8.
Kohn GP, Price RR, DeMeester SR, Zehetner J, Muensterer OJ, Awad Z, et al. Guidelines for the management of hiatal hernia. Surg Endosc. 2013 Dec;27(12):4409-28. doi: 10.1007/s00464-013-3173-3. Epub 2013 Sep 10. PMID: 24018762.
This work is licensed under a Creative Commons Attribution 4.0 International License.